Pioneering research into a “game-changing” new antibiotic by a team of scientists at the University of Lincoln has been featured in a leading microbiology journal.
Led by Dr Ishwar Singh from the University’s School of Pharmacy, the team is working to test and develop teixobactin – a new antibiotic hailed as the “last line of defence” in the battle against drug-resistant superbugs such as MRSA and VRE.
An editorial feature by the team has now been published in Future Microbiology. The article highlights the current challenges, opportunities and forward directions for realising and utilising the therapeutic potential of Teixobactin.